Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationBone MarrowTransplantation, HomologousTransplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow CellsGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematopoietic Stem CellsTransplantation ConditioningWhole-Body IrradiationGranulocyte Colony-Stimulating FactorGraft SurvivalStem CellsBusulfanAnemia, AplasticCyclophosphamideLeukapheresisTransplantation ChimeraLeukemiaBone and BonesAntigens, CD34Tissue DonorsHematologic NeoplasmsCombined Modality TherapyBone Marrow PurgingHematopoiesisHistocompatibility TestingHistocompatibilityLiver TransplantationBlood Component RemovalStem Cell TransplantationRecurrenceTransplantation, IsogeneicBone Marrow DiseasesTreatment OutcomeMelphalanLymphoma, Non-HodgkinRemission InductionTime FactorsAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteColony-Forming Units AssayBlood CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsMice, Inbred C57BLMultiple MyelomaT-LymphocytesCell DifferentiationBlood Cell CountKidney TransplantationFlow CytometryEtoposideLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaCord Blood Stem Cell TransplantationCells, CulturedLeukocyte TransfusionRadiation ChimeraLeukemia, MyeloidRetrospective StudiesTransplantation ImmunologyAcute DiseaseLeukocyte CountSurvival AnalysisImmunosuppressionMyelodysplastic SyndromesBone Marrow ExaminationCytarabineCell SeparationHematologic DiseasesHLA AntigensImmunophenotypingGraft RejectionHepatic Veno-Occlusive DiseaseDisease-Free SurvivalLeukocytes, MononuclearSurvival RateCyclosporineCarmustineBone RemodelingAntigens, CDBone Marrow NeoplasmsNuclear FamilyLymphocyte TransfusionLymphomaInfectionCytomegalovirus InfectionsGranulocytesGraft vs Host ReactionChimeraHodgkin DiseaseFollow-Up StudiesThiotepaPlatelet CountGraft vs Leukemia EffectMyeloablative AgonistsCell Lineage